Development of Immortalized Cell Lines from Hereditary Prostate Cancer Families
Abstract
Prostate cancer is a significant cause of morbidity and mortality in the United States. Several types of epidemiological studies confirm the existence of a genetic component to prostate cancer etiology. Hereditary prostate cancer (HPC) genes are predicted to account for about 43% of disease in men over 55, and 9% of total prostate cancer in men diagnosed through age 85. To best utilize the finite amount of DNA in blood samples previously collected from 271 HPC families, we are creating immortalized cell lines. The objective is to generate a long term resource of germline DNA from HPC families for use in mapping gene pathways associated with disease susceptibility.
Document Details
- Document Type
- Technical Report
- Publication Date
- Sep 01, 2006
- Accession Number
- ADA484352
Entities
People
- Elaine Ostrander
- Janet Stanford
Organizations
- Fred Hutchinson Cancer Center